![]() |
市場調查報告書
商品編碼
1968457
診斷影像服務市場-全球產業規模、佔有率、趨勢、機會、預測:按模式、應用、區域和競爭格局分類,2021-2031年Diagnostic Imaging Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Modality, By Application, By Region & Competition, 2021-2031F |
||||||
全球診斷影像服務市場預計將從 2025 年的 6,476.4 億美元成長到 2031 年的 9,275.7 億美元,複合年成長率為 6.17%。
該領域涵蓋醫學影像診斷技術,例如X光、電腦斷層掃描(CT)、磁振造影(MRI)和超音波,這些技術用於對人體進行可視化,以達到診斷和治療的目的。市場成長的主要促進因素是全球人口老化以及需要頻繁、精準監測的慢性疾病數量不斷增加。此外,影像技術的進步正在擴大臨床應用範圍,並提升病患照護能力。例如,英國皇家放射學院的一份報告預測,到2024年,英國對CT和MRI成像的需求英國增加8%,凸顯了主要醫療保健系統面臨的日益成長的壓力和不斷提高的使用率。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 6476.4億美元 |
| 市場規模:2031年 | 9275.7億美元 |
| 複合年成長率:2026-2031年 | 6.17% |
| 成長最快的細分市場 | X光 |
| 最大的市場 | 北美洲 |
儘管需求強勁,市場仍面臨勞動力能力和營運成本的重大挑戰。放射科醫師和技術人員的嚴重短缺限制了醫療機構應對掃描需求激增的能力,常常導致診斷延誤。設備所需的高額資本投入以及外包積壓病例處理服務帶來的經濟負擔進一步加劇了這一瓶頸。因此,無法擴大人員配備規模以滿足診斷影像需求,成為全球診斷影像服務順利擴張的主要障礙。
慢性病和文明病的日益普遍是全球診斷影像服務市場的主要驅動力。隨著心血管疾病和惡性腫瘤等疾病的日益蔓延,臨床上對先進影像技術在精準診斷、分期和後續觀察的依賴性也日益增強。這一趨勢在腫瘤學領域尤為顯著,篩檢和診斷程序的數量正在穩步成長,因為早期發現對於提高患者存活率至關重要。根據美國癌症協會發布的《2024年癌症事實與數據》報告,預計2024年美國將新增超過200萬例癌症病例,凸顯了日益沉重的疾病負擔,也凸顯了對全面影像支持的需求。
第二個主要驅動力是技術進步與人工智慧(AI)的融合。這些技術正在透過提高診斷準確性和營運效率來改變醫療服務的提供方式。人工智慧演算法的日益普及,旨在實現影像分析自動化、縮短檢查時間並優先處理急診病例,這對於應對放射科面臨的巨大壓力至關重要。根據MedTech Dive在2024年10月報道,美國食品藥物管理局(FDA)的數據顯示,截至2024年8月,該機構已核准了950種人工智慧驅動的醫療設備,其中絕大多數(723種)應用於放射學領域。這些技術對於緩解系統性壓力至關重要,英國國家醫療服務體系(NHS England)的數據顯示,截至2024年8月,約有156萬名患者正在等待診斷檢測,這充分說明了這些技術的必要性。
合格放射科醫師和技術人員的短缺是限制全球診斷影像服務市場成長的一大結構性障礙。即使醫療機構能夠部署先進的影像系統,缺乏操作這些設備和解讀掃描結果的熟練人員也會造成嚴重的營運瓶頸。設備可用性和人員能力之間的這種差距迫使醫療機構限制服務量,導致患者等待時間延長,並阻礙了診斷能力的自然擴張。人員不足會導致醫療機構無法最大限度地利用其影像設備,從而直接限制產生收入和服務擴充性。
因此,醫療機構為彌補人員短缺而增加的營運成本正在急劇上升。醫療系統越來越依賴昂貴的臨時人員和外包影像判讀服務來清理積壓的未處理病例,從而將大量資金從基礎設施投資中轉移出去。英國皇家放射學院在2024年報告稱,英國臨床放射科顧問將出現30%的缺口。這種長期的勞動力短缺迫使醫療機構優先考慮維持營運而非擴張,阻礙了診斷影像領域的更廣泛發展。
將診斷影像服務轉移到門診和護理機構,從根本上改變了病患的就醫路徑,使診斷資源不再集中在不堪重負的急診醫院。這一趨勢的驅動力在於消除營運瓶頸、降低檢測成本,並透過社區服務模式提升病患就醫便利性。政府和私人醫療機構正積極拓展此類網路,旨在管理候診名單,並將診斷流程與急診流程選擇性地分開。根據英國國家醫療服務體系(NHS)英格蘭分部2024年9月發布的社區診斷中心最新進展,這項全國性舉措已成功擴展至165個運作點,自啟動以來已完成超過900萬次檢測、檢查和掃描,凸顯了對分散式服務的強勁需求。
治療診斷學(治療性診斷)和精準核醫學的出現,標誌著診斷影像與標靶治療直接結合的變革性發展。這種方法利用特定的放射性藥物來識別癌細胞上的獨特分子標靶,並進行局部治療,從而有效地將診斷和治療整合到一個精準的工作流程中。領先製造商的顯著收入成長推動了這些藥物的快速商業性,創造了超越傳統硬體的新價值。例如,GE醫療在2023年第四季財報中宣布,其藥物診斷部門第四季實現了23%的有機收入成長,凸顯了其對分子影像解決方案日益成長的市場依賴。
The Global Diagnostic Imaging Services Market is projected to expand from USD 647.64 Billion in 2025 to USD 927.57 Billion by 2031, reflecting a CAGR of 6.17%. This sector encompasses the provision of medical imaging procedures such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound, which are utilized to visualize the human body for diagnostic and treatment purposes. Market growth is primarily driven by an aging global population and the increasing prevalence of chronic diseases, which require frequent and accurate monitoring. Additionally, technological advancements in imaging modalities are broadening clinical applications and improving patient throughput; for instance, the Royal College of Radiologists reported an 8% increase in demand for CT and MRI imaging activity in the United Kingdom in 2024, highlighting the intensifying pressure and rising utilization rates within major healthcare systems.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 647.64 Billion |
| Market Size 2031 | USD 927.57 Billion |
| CAGR 2026-2031 | 6.17% |
| Fastest Growing Segment | X-ray |
| Largest Market | North America |
Despite these positive demand indicators, the market encounters significant hurdles related to workforce capacity and operational costs. A critical shortage of radiologists and technical staff restricts the ability of healthcare facilities to handle the growing volume of scan requests, frequently leading to diagnostic delays. This bottleneck is further aggravated by the high capital expenditure necessary for equipment and the financial burden of outsourcing reporting services to clear backlogs. Consequently, the inability to scale staffing levels to match imaging demand remains a substantial barrier preventing the seamless expansion of diagnostic imaging services worldwide.
Market Driver
The rising prevalence of chronic and lifestyle-related diseases acts as a primary catalyst for the global diagnostic imaging services market. As conditions such as cardiovascular disorders and malignancies become more widespread, clinical reliance on advanced imaging modalities for precise diagnosis, staging, and treatment monitoring intensifies. This trend is particularly notable in oncology, where early detection is vital for patient survival, driving a sustained increase in screening and diagnostic procedure volumes. According to the American Cancer Society's 'Cancer Facts & Figures 2024' report, the United States is projected to see over 2 million new cancer cases in 2024, a milestone that emphasizes the growing disease burden requiring comprehensive imaging support.
Technological advancements and the integration of artificial intelligence (AI) serve as the second major driver, reshaping service delivery by improving diagnostic precision and operational efficiency. AI algorithms are increasingly being deployed to automate image analysis, reduce scan times, and prioritize urgent cases, which is essential for managing the high demand placed on radiology departments. As reported by MedTech Dive in October 2024, FDA data indicates that as of August 2024, the agency had authorized 950 AI-enabled medical devices, with radiology applications comprising the majority at 723 devices. These technologies are crucial for mitigating systemic pressures, a need highlighted by NHS England data showing approximately 1.56 million patients waiting for a diagnostic test as of August 2024.
Market Challenge
The shortage of qualified radiologists and technical staff presents a significant structural barrier to the growth of the Global Diagnostic Imaging Services Market. Although healthcare providers can acquire advanced imaging systems, the scarcity of specialized personnel needed to operate these machines and interpret scans creates a severe operational bottleneck. This disconnect between equipment availability and workforce capacity compels facilities to limit service volumes, resulting in extended patient wait times and hindering the organic expansion of diagnostic capabilities. Without an adequate workforce, facilities are unable to maximize the utilization of their imaging assets, which directly constrains revenue generation and service scalability.
As a result, the market contends with inflated operational expenditures as providers attempt to bridge this staffing gap. Healthcare systems increasingly rely on expensive temporary staffing or outsourced reporting services to clear mounting backlogs, diverting critical capital away from infrastructure investment. The Royal College of Radiologists reported in 2024 that the United Kingdom faced a 30 percent shortfall in clinical radiology consultants. This chronic labor deficit forces healthcare organizations to prioritize operational maintenance over expansion, thereby impeding the broader development of the diagnostic imaging sector.
Market Trends
The shift of imaging services toward outpatient and ambulatory care settings is fundamentally altering patient pathways by decentralizing diagnostic access away from overburdened acute hospital facilities. This trend is driven by the need to alleviate operational bottlenecks, lower procedural costs, and enhance patient convenience through community-based delivery models. Governments and private providers are aggressively expanding these networks to manage waitlists and separate elective diagnostics from emergency workflows. According to an NHS England update in September 2024 regarding Community Diagnostic Centres, the national initiative has successfully scaled to 165 operational sites, delivering over 9 million tests, checks, and scans since the program began, validating the strong demand for decentralized services.
The emergence of theranostics and precision nuclear medicine represents a transformative evolution wherein diagnostic imaging is directly coupled with targeted therapeutic delivery. This approach employs specific radiopharmaceuticals to identify unique molecular targets on tumor cells and deliver localized treatment, effectively merging diagnosis and therapy into a single precision workflow. The rapid commercial adoption of these agents is evidenced by significant revenue increases for key industry manufacturers, creating value streams beyond traditional hardware. For example, GE HealthCare reported in its 'Fourth Quarter 2023 Financial Results' that its Pharmaceutical Diagnostics segment achieved 23% organic revenue growth in the fourth quarter, underscoring the intensifying market reliance on molecular imaging solutions.
Report Scope
In this report, the Global Diagnostic Imaging Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Diagnostic Imaging Services Market.
Global Diagnostic Imaging Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: